Metered dose inhaler (MDI)

Manufacturer of components for metered dose inhalers (MDIs), H&T Presspart, is collaborating with Hovione Technology for the expansion of its portfolio of novel drug delivery systems in respiratory care. Read more


Mylan has launched the first bioequivalent alternative to GlaxoSmithKline’s Seretide Evohaler (salmeterol xinafoate/fluticasone propionate) under the brand name Sirdupla in the UK. Read more


The company launches Serroflo, its Salmeterol/Fluticasone MDI, in Germany and Sweden. Read more